We initially examined the effects of compound 11 on proliferative activity and viability of human colon cancer cell lines, HCT116 (p53 wild-type, Figure 1A) and HT-29 (p53 mutant, Figure 1B). This evidence concerns the gene TP53 and malignant colon neoplasm.